NCT07788040Enrolling by invitation
Intracardiac Echocardiography Catheter Supply-Chain Reliability and Clinical Access Study
Prospective Observational Evaluation of Procurement Reliability, Distribution Restrictions, Supply-Chain Disruptions, and Clinical Access to Intracardiac Echocardiography Catheters
Source: ClinicalTrials.gov · Last updated 26 Oct 2026
Brief summary (registry, in English)
The ICE-ACCESS study is a prospective observational study designed to evaluate how procurement reliability, distribution restrictions, supply-chain interruptions, and device availability affect access to intracardiac echocardiography (ICE) catheters and related clinical care. The study will document real-world procurement attempts, fulfillment outcomes, order delays, cancellations, product substitutions, distributor restrictions, acquisition timelines, and other supply-access events involving ICE catheter devices. Where participant-level clinical data are available under the approved protocol, the study will also examine whether device-access problems are associated with procedure delays, rescheduling, changes in planned device use, alternative sourcing, increased administrative burden, or other measurable effects on care delivery. The study does not assign participants to a device or treatment and does not alter clinical decision-making. Procurement and clinical events are observed as they occur in routine practice. The study is intended to develop a structured evidence base for understanding the reliability of the medical-device supply chain and the potential relationship between procurement disruption and timely access to cardiovascular procedures.
- Status (registry)
- Enrolling by invitation
- Study type
- Observational
- Enrollment
- 200 (estimated)
- First submitted
- 23 Aug 2026
- Start date
- 23 Oct 2026
- Primary completion date
- 31 Aug 2027
- Lead sponsor
- Truway Health, Inc.
- Diseases
- Atrial fibrillation
- NCT number
- NCT07788040
What you commit to
- Study type: Observational
- Planned participants: 200
- From 23 Oct 2026 to the primary completion date, 31 Aug 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Younger than 18 years of age.
Other
- No planned, requested, or clinically relevant intracardiac echocardiography catheter involvement in the associated cardiovascular procedure.
- Procurement or clinical records are insufficient to establish the timing or final disposition of the device-access episode.
- Device access occurred outside the predefined study observation period.
- Procedure delay or cancellation is clearly attributable solely to an unrelated clinical or administrative circumstance and no qualifying ICE catheter access event occurred.
- Participation would conflict with another protocol, institutional restriction, or applicable human-subject protection requirement.
- Individuals for whom required authorization, consent, or permitted IRB-approved waiver criteria are not satisfied.
Who the study is looking for
- Age 18 years or older.
- Participant is scheduled for, referred for, or undergoing an electrophysiology, cardiac ablation, structural heart, or other cardiovascular procedure for which intracardiac echocardiography or an ICE catheter is clinically planned, requested, considered, or utilized.
- A documented ICE-catheter procurement or device-access episode can be identified and evaluated under the study protocol.
- Sufficient procurement, scheduling, clinical, or administrative information is available to determine device-access timing and study outcomes.
- Participant falls within either the documented ICE catheter access-disruption cohort or the timely-access comparison cohort.
- Able to provide informed consent when prospective consent is required by the applicable IRB determination, or eligible for inclusion under an IRB-approved waiver or alteration of consent where applicable.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Truway Health, Inc. Coordinator of this site? Confirm its status | New York | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.